Metabolism of Ginsenoside Rc by Human Intestinal Bacteria and Its Related Antiallergic Activity

When ginsenoside Rc was anaerobically incubated with human fecal microflora, all specimens metabolized ginsenoside Rc to compound K and protopanaxadiol. The main metabolite was compound K. Among the bacteria isolated from human fecal microflora, most bacteria, such as Bacteroides sp., Eubacterium sp...

Full description

Saved in:
Bibliographic Details
Published in:Biological & pharmaceutical bulletin 2002, Vol.25(6), pp.743-747
Main Authors: Bae, Eun-Ah, Choo, Min-Kyung, Park, Eun-Kyung, Park, Sun-Young, Shin, Ho-Young, Kim, Dong-Hyun
Format: Article
Language:English
Subjects:
antiallergy
Biological and medical sciences
compound K
General pharmacology
ginsenoside Mb
ginsenoside Rc
intestinal bacteria
Medical sciences
Pharmacognosy. Homeopathy. Health food
Pharmacology. Drug treatments
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c5103-b13d6939e76784e44762ff25eec4b7bc24799935dac9572ea7397da23f0c12ab3
cites cdi_FETCH-LOGICAL-c5103-b13d6939e76784e44762ff25eec4b7bc24799935dac9572ea7397da23f0c12ab3
container_end_page 747
container_issue 6
container_start_page 743
container_title Biological & pharmaceutical bulletin
container_volume 25
creator Bae, Eun-Ah
Choo, Min-Kyung
Park, Eun-Kyung
Park, Sun-Young
Shin, Ho-Young
Kim, Dong-Hyun
description When ginsenoside Rc was anaerobically incubated with human fecal microflora, all specimens metabolized ginsenoside Rc to compound K and protopanaxadiol. The main metabolite was compound K. Among the bacteria isolated from human fecal microflora, most bacteria, such as Bacteroides sp., Eubacterium sp., and Bifidobacterium sp. potently transformed ginsenoside Rc to compound K. Bifidobacterium K-103 and Eubacterium A-44 transformed it to compound K via ginsenoside Rd, and Bacteroides HJ-15 and Bifidobacterium K-506 metabolized to compound K via ginsenoside Mb, which was isolated as a new metabolite (M.W. 940[+Na]). Among ginsenoside Rc and its metabolites, compound K exhibited the most potent antiallergic activity on the IgE-induced RBL cell line as well as potent cytotoxic activity against tumor cell lines.
doi_str_mv 10.1248/bpb.25.743
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1449197708</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3120516201</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5103-b13d6939e76784e44762ff25eec4b7bc24799935dac9572ea7397da23f0c12ab3</originalsourceid><addsrcrecordid>eNpFkE1rGzEQhkVoIK7TS36BoPRSWFefq9WpuKF1DCmBkJ7FrHY2kVlrXUkO-N93ix3nMnOYZx5eXkJuOFtwoZpv7a5dCL0wSl6QGZfKVFpw_YHMmOVNVXPdXJGPOW8YY4YJOSPuNxZoxyHkLR17ugoxYxxz6JA-etoe6N1-C5GuY8FcQoSB_gBfMAWgEDu6Lpk-4gAFO7qMJcAwYHoOni59Ca-hHK7JZQ9Dxk-nPSd_fv18ur2r7h9W69vlfeU1Z7JquexqKy2a2jQKlTK16HuhEb1qTeuFMtZaqTvwVhuBYKQ1HQjZM88FtHJOPh-9uzT-3U9Z3Wbcpylvdlwpy60xrJmor0fKpzHnhL3bpbCFdHCcuf8FuqlAJ7SbCpzgLyclZA9DnyD6kN8_pDG6Vmrivh-5TS7wjGcAUgl-wDdlfRyT-XzxL5AcRvkPMqGGrQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1449197708</pqid></control><display><type>article</type><title>Metabolism of Ginsenoside Rc by Human Intestinal Bacteria and Its Related Antiallergic Activity</title><source>Free Full-Text Journals in Chemistry</source><creator>Bae, Eun-Ah ; Choo, Min-Kyung ; Park, Eun-Kyung ; Park, Sun-Young ; Shin, Ho-Young ; Kim, Dong-Hyun</creator><creatorcontrib>Bae, Eun-Ah ; Choo, Min-Kyung ; Park, Eun-Kyung ; Park, Sun-Young ; Shin, Ho-Young ; Kim, Dong-Hyun</creatorcontrib><description>When ginsenoside Rc was anaerobically incubated with human fecal microflora, all specimens metabolized ginsenoside Rc to compound K and protopanaxadiol. The main metabolite was compound K. Among the bacteria isolated from human fecal microflora, most bacteria, such as Bacteroides sp., Eubacterium sp., and Bifidobacterium sp. potently transformed ginsenoside Rc to compound K. Bifidobacterium K-103 and Eubacterium A-44 transformed it to compound K via ginsenoside Rd, and Bacteroides HJ-15 and Bifidobacterium K-506 metabolized to compound K via ginsenoside Mb, which was isolated as a new metabolite (M.W. 940[+Na]). Among ginsenoside Rc and its metabolites, compound K exhibited the most potent antiallergic activity on the IgE-induced RBL cell line as well as potent cytotoxic activity against tumor cell lines.</description><identifier>ISSN: 0918-6158</identifier><identifier>EISSN: 1347-5215</identifier><identifier>DOI: 10.1248/bpb.25.743</identifier><language>eng</language><publisher>Tokyo: The Pharmaceutical Society of Japan</publisher><subject>antiallergy ; Biological and medical sciences ; compound K ; General pharmacology ; ginsenoside Mb ; ginsenoside Rc ; intestinal bacteria ; Medical sciences ; Pharmacognosy. Homeopathy. Health food ; Pharmacology. Drug treatments</subject><ispartof>Biological and Pharmaceutical Bulletin, 2002, Vol.25(6), pp.743-747</ispartof><rights>2002 The Pharmaceutical Society of Japan</rights><rights>2002 INIST-CNRS</rights><rights>Copyright Japan Science and Technology Agency 2002</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5103-b13d6939e76784e44762ff25eec4b7bc24799935dac9572ea7397da23f0c12ab3</citedby><cites>FETCH-LOGICAL-c5103-b13d6939e76784e44762ff25eec4b7bc24799935dac9572ea7397da23f0c12ab3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=13775644$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Bae, Eun-Ah</creatorcontrib><creatorcontrib>Choo, Min-Kyung</creatorcontrib><creatorcontrib>Park, Eun-Kyung</creatorcontrib><creatorcontrib>Park, Sun-Young</creatorcontrib><creatorcontrib>Shin, Ho-Young</creatorcontrib><creatorcontrib>Kim, Dong-Hyun</creatorcontrib><title>Metabolism of Ginsenoside Rc by Human Intestinal Bacteria and Its Related Antiallergic Activity</title><title>Biological &amp; pharmaceutical bulletin</title><description>When ginsenoside Rc was anaerobically incubated with human fecal microflora, all specimens metabolized ginsenoside Rc to compound K and protopanaxadiol. The main metabolite was compound K. Among the bacteria isolated from human fecal microflora, most bacteria, such as Bacteroides sp., Eubacterium sp., and Bifidobacterium sp. potently transformed ginsenoside Rc to compound K. Bifidobacterium K-103 and Eubacterium A-44 transformed it to compound K via ginsenoside Rd, and Bacteroides HJ-15 and Bifidobacterium K-506 metabolized to compound K via ginsenoside Mb, which was isolated as a new metabolite (M.W. 940[+Na]). Among ginsenoside Rc and its metabolites, compound K exhibited the most potent antiallergic activity on the IgE-induced RBL cell line as well as potent cytotoxic activity against tumor cell lines.</description><subject>antiallergy</subject><subject>Biological and medical sciences</subject><subject>compound K</subject><subject>General pharmacology</subject><subject>ginsenoside Mb</subject><subject>ginsenoside Rc</subject><subject>intestinal bacteria</subject><subject>Medical sciences</subject><subject>Pharmacognosy. Homeopathy. Health food</subject><subject>Pharmacology. Drug treatments</subject><issn>0918-6158</issn><issn>1347-5215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNpFkE1rGzEQhkVoIK7TS36BoPRSWFefq9WpuKF1DCmBkJ7FrHY2kVlrXUkO-N93ix3nMnOYZx5eXkJuOFtwoZpv7a5dCL0wSl6QGZfKVFpw_YHMmOVNVXPdXJGPOW8YY4YJOSPuNxZoxyHkLR17ugoxYxxz6JA-etoe6N1-C5GuY8FcQoSB_gBfMAWgEDu6Lpk-4gAFO7qMJcAwYHoOni59Ca-hHK7JZQ9Dxk-nPSd_fv18ur2r7h9W69vlfeU1Z7JquexqKy2a2jQKlTK16HuhEb1qTeuFMtZaqTvwVhuBYKQ1HQjZM88FtHJOPh-9uzT-3U9Z3Wbcpylvdlwpy60xrJmor0fKpzHnhL3bpbCFdHCcuf8FuqlAJ7SbCpzgLyclZA9DnyD6kN8_pDG6Vmrivh-5TS7wjGcAUgl-wDdlfRyT-XzxL5AcRvkPMqGGrQ</recordid><startdate>2002</startdate><enddate>2002</enddate><creator>Bae, Eun-Ah</creator><creator>Choo, Min-Kyung</creator><creator>Park, Eun-Kyung</creator><creator>Park, Sun-Young</creator><creator>Shin, Ho-Young</creator><creator>Kim, Dong-Hyun</creator><general>The Pharmaceutical Society of Japan</general><general>Maruzen</general><general>Japan Science and Technology Agency</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TK</scope><scope>7U9</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope></search><sort><creationdate>2002</creationdate><title>Metabolism of Ginsenoside Rc by Human Intestinal Bacteria and Its Related Antiallergic Activity</title><author>Bae, Eun-Ah ; Choo, Min-Kyung ; Park, Eun-Kyung ; Park, Sun-Young ; Shin, Ho-Young ; Kim, Dong-Hyun</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5103-b13d6939e76784e44762ff25eec4b7bc24799935dac9572ea7397da23f0c12ab3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>antiallergy</topic><topic>Biological and medical sciences</topic><topic>compound K</topic><topic>General pharmacology</topic><topic>ginsenoside Mb</topic><topic>ginsenoside Rc</topic><topic>intestinal bacteria</topic><topic>Medical sciences</topic><topic>Pharmacognosy. Homeopathy. Health food</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bae, Eun-Ah</creatorcontrib><creatorcontrib>Choo, Min-Kyung</creatorcontrib><creatorcontrib>Park, Eun-Kyung</creatorcontrib><creatorcontrib>Park, Sun-Young</creatorcontrib><creatorcontrib>Shin, Ho-Young</creatorcontrib><creatorcontrib>Kim, Dong-Hyun</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Biological &amp; pharmaceutical bulletin</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bae, Eun-Ah</au><au>Choo, Min-Kyung</au><au>Park, Eun-Kyung</au><au>Park, Sun-Young</au><au>Shin, Ho-Young</au><au>Kim, Dong-Hyun</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Metabolism of Ginsenoside Rc by Human Intestinal Bacteria and Its Related Antiallergic Activity</atitle><jtitle>Biological &amp; pharmaceutical bulletin</jtitle><date>2002</date><risdate>2002</risdate><volume>25</volume><issue>6</issue><spage>743</spage><epage>747</epage><pages>743-747</pages><issn>0918-6158</issn><eissn>1347-5215</eissn><abstract>When ginsenoside Rc was anaerobically incubated with human fecal microflora, all specimens metabolized ginsenoside Rc to compound K and protopanaxadiol. The main metabolite was compound K. Among the bacteria isolated from human fecal microflora, most bacteria, such as Bacteroides sp., Eubacterium sp., and Bifidobacterium sp. potently transformed ginsenoside Rc to compound K. Bifidobacterium K-103 and Eubacterium A-44 transformed it to compound K via ginsenoside Rd, and Bacteroides HJ-15 and Bifidobacterium K-506 metabolized to compound K via ginsenoside Mb, which was isolated as a new metabolite (M.W. 940[+Na]). Among ginsenoside Rc and its metabolites, compound K exhibited the most potent antiallergic activity on the IgE-induced RBL cell line as well as potent cytotoxic activity against tumor cell lines.</abstract><cop>Tokyo</cop><pub>The Pharmaceutical Society of Japan</pub><doi>10.1248/bpb.25.743</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-6158
ispartof Biological and Pharmaceutical Bulletin, 2002, Vol.25(6), pp.743-747
issn 0918-6158
1347-5215
language eng
recordid cdi_proquest_journals_1449197708
source Free Full-Text Journals in Chemistry
subjects antiallergy
Biological and medical sciences
compound K
General pharmacology
ginsenoside Mb
ginsenoside Rc
intestinal bacteria
Medical sciences
Pharmacognosy. Homeopathy. Health food
Pharmacology. Drug treatments
title Metabolism of Ginsenoside Rc by Human Intestinal Bacteria and Its Related Antiallergic Activity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T20%3A13%3A58IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Metabolism%20of%20Ginsenoside%20Rc%20by%20Human%20Intestinal%20Bacteria%20and%20Its%20Related%20Antiallergic%20Activity&rft.jtitle=Biological%20&%20pharmaceutical%20bulletin&rft.au=Bae,%20Eun-Ah&rft.date=2002&rft.volume=25&rft.issue=6&rft.spage=743&rft.epage=747&rft.pages=743-747&rft.issn=0918-6158&rft.eissn=1347-5215&rft_id=info:doi/10.1248/bpb.25.743&rft_dat=%3Cproquest_cross%3E3120516201%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c5103-b13d6939e76784e44762ff25eec4b7bc24799935dac9572ea7397da23f0c12ab3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1449197708&rft_id=info:pmid/&rfr_iscdi=true